Trial Profile
A Phase I/II Study of Human Cord Blood Mononuclear Cells and Human Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Hormone Replacement Therapy in Patients With Premature Ovarian Failure
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Blood mononuclear cell therapy (Primary) ; Umbilical cord mesenchymal stem cell therapy-Beike (Primary) ; Hormonal replacements
- Indications Primary ovarian insufficiency
- Focus Therapeutic Use
- 09 Jan 2013 New trial record